Literature DB >> 7595213

Cloning and expression of a Leishmania donovani gene instructed by a peptide isolated from major histocompatibility complex class II molecules of infected macrophages.

A Campos-Neto1, L Soong, J L Cordova, D Sant'Angelo, Y A Skeiky, N H Ruddle, S G Reed, C Janeway, D McMahon-Pratt.   

Abstract

The studies reported here describe the isolation of peptides from MHC class II molecules of murine macrophages infected with Leishmania donovani, and the use of the derived peptide sequences to rescue the pathogen peptide donor protein. The isolation of the peptides was carried out by comparing the RP HPLC profile of peptides extracted from infected macrophages with the peptides extracted from noninfected cells. Several distinct HPLC peaks unique to infected macrophages were sequenced. One of the peptides that was not homologous to any known protein was used to instruct the designing of an oligonucleotide sense primer that was used in combination with an oligo dT nucleotide (anti-sense primer) to amplify by PCR a DNA fragment from L. donovani cDNA. The amplified DNA fragment was cloned and used as a probe to screen a L. donovani cDNA library. The cloned gene (Ld peptide gene) has an open reading frame of 525 bp and has no homology with any known protein/gene sequence. Northern blot analyses indicated that the Ld peptide/gene is broadly distributed and expressed among species of the Leishmania genus, in both the amastigote and promastigote life cycle forms. Using the pGEX 2T vector, the gene was expressed and the relationship of the purified recombinant protein with L. donovani was confirmed using both antibody and T cell responses from immunized or infected animals. The gene encodes a 23-kD molecule (Ldp 23) associated with the cell surface of L. donovani promastigotes. In addition, T cells purified from the lymph nodes of BALB/c mice immunized with L. donovani or infected with L. major, and from CBA/J mice infected with L. amazonensis were stimulated to proliferate by the recombinant Ldp 23 and produced high levels of IFN-gamma and no IL 4. This observation suggests that the Ldp 23 is an interesting parasite molecule for the studies concerning the host/parasite interaction because the Th1 pattern of cytokine response that it induces is correlated with resistance to Leishmania infections. These results clearly point to an alternative strategy for the purification of proteins useful for the development of both vaccines and immunological diagnostic tools not only against leishmaniasis but also for other diseases caused by intracellular pathogens.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7595213      PMCID: PMC2192207          DOI: 10.1084/jem.182.5.1423

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  44 in total

1.  Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs.

Authors:  P Preston-Hurlburt; B K al-Ramadi; J Rothbard; C A Janeway
Journal:  Nature       Date:  1992-10-01       Impact factor: 49.962

2.  Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad.

Authors:  D F Hunt; H Michel; T A Dickinson; J Shabanowitz; A L Cox; K Sakaguchi; E Appella; H M Grey; A Sette
Journal:  Science       Date:  1992-06-26       Impact factor: 47.728

3.  The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC.

Authors:  D R Madden; J C Gorga; J L Strominger; D C Wiley
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

4.  Leishmania: codon utilization of nuclear genes.

Authors:  C K Langford; B Ullman; S M Landfear
Journal:  Exp Parasitol       Date:  1992-05       Impact factor: 2.011

Review 5.  Chemistry of peptide interactions with MHC proteins.

Authors:  A Sette; H M Grey
Journal:  Curr Opin Immunol       Date:  1992-02       Impact factor: 7.486

6.  Identification of self peptides bound to purified HLA-B27.

Authors:  T S Jardetzky; W S Lane; R A Robinson; D R Madden; D C Wiley
Journal:  Nature       Date:  1991-09-26       Impact factor: 49.962

7.  Lectin(s) extracted from seeds of Artocarpus integrifolia (jackfruit): potent and selective stimulator(s) of distinct human T and B cell functions.

Authors:  M M Bunn-Moreno; A Campos-Neto
Journal:  J Immunol       Date:  1981-08       Impact factor: 5.422

8.  Selective inability of spleen antigen presenting cells from Leishmania donovani infected hamsters to mediate specific T cell proliferation to parasite antigens.

Authors:  V Rodrigues Júnior; J S Da Silva; A Campos-Neto
Journal:  Parasite Immunol       Date:  1992-01       Impact factor: 2.280

9.  IL-4 induces a Th2 response in Leishmania major-infected mice.

Authors:  R Chatelain; K Varkila; R L Coffman
Journal:  J Immunol       Date:  1992-02-15       Impact factor: 5.422

10.  Endogenous peptides of a soluble major histocompatibility complex class I molecule, H-2Lds: sequence motif, quantitative binding, and molecular modeling of the complex.

Authors:  M Corr; L F Boyd; S R Frankel; S Kozlowski; E A Padlan; D H Margulies
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

View more
  15 in total

1.  A novel Leishmania infantum recombinant antigen which elicits interleukin 10 production by peripheral blood mononuclear cells of patients with visceral leishmaniasis.

Authors:  I Suffia; B Ferrua; X Stien; B Mograbi; P Marty; D Rousseau; K Fragaki; J Kubar
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Protective immunization against visceral leishmaniasis using Leishmania sterol 24-c-methyltransferase formulated in adjuvant.

Authors:  Yasuyuki Goto; Lisa Y Bogatzki; Sylvie Bertholet; Rhea N Coler; Steven G Reed
Journal:  Vaccine       Date:  2007-08-20       Impact factor: 3.641

Review 3.  Leishmaniasis: current status of vaccine development.

Authors:  E Handman
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

4.  Utility of the Trypanosoma cruzi sequence database for identification of potential vaccine candidates by in silico and in vitro screening.

Authors:  Vandanajay Bhatia; Mala Sinha; Bruce Luxon; Nisha Garg
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

5.  Leishmania chagasi T-cell antigens identified through a double library screen.

Authors:  Daniella R A Martins; Selma M B Jeronimo; John E Donelson; Mary E Wilson
Journal:  Infect Immun       Date:  2006-09-25       Impact factor: 3.441

6.  Prophylactic efficacy of TcVac2 against Trypanosoma cruzi in mice.

Authors:  Shivali Gupta; Nisha Jain Garg
Journal:  PLoS Negl Trop Dis       Date:  2010-08-10

7.  Cloning and characterization of a gene encoding an immunoglobulin-binding receptor on the cell surface of some members of the family Trypanosomatidae.

Authors:  Antonio Campos-Neto; Isabelle Suffia; Karen A Cavassani; Shyian Jen; Kay Greeson; Pamela Ovendale; João S Silva; Steven G Reed; Yasir A W Skeiky
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

8.  Potential serological use of a recombinant protein that is a replica of a Mycobacterium tuberculosis protein found in the urine of infected mice.

Authors:  Sandeep Mukherjee; Nada Daifalla; Yanni Zhang; John Douglass; Lisa Brooks; Thomas Vedvick; Raymond Houghton; Steven G Reed; Antonio Campos-Neto
Journal:  Clin Diagn Lab Immunol       Date:  2004-03

9.  An unbiased peptide-wide discovery approach to select Mycobacterium tuberculosis antigens that target CD8+ T cell response during infection.

Authors:  Mark J Cayabyab; Lizeng Qin; Suely S Kashino; Angelo Izzo; Antonio Campos-Neto
Journal:  Vaccine       Date:  2013-08-09       Impact factor: 3.641

10.  Human and murine immune responses to a novel Leishmania major recombinant protein encoded by members of a multicopy gene family.

Authors:  J R Webb; A Campos-Neto; P J Ovendale; T I Martin; E J Stromberg; R Badaro; S G Reed
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.